1
|
Improta L, Tzanis D, Bouhadiba T,
Abdelhafidh K and Bonvalot S: Overview of primary adult
retroperitoneal tumours. Eur J Surg Oncol. 46:1573–1579. 2020.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Sbaraglia M, Bellan E and Dei Tos AP: The
2020 WHO Classification of Soft Tissue Tumours: News and
perspectives. Pathologica. 113:70–84. 2021. View Article : Google Scholar : PubMed/NCBI
|
3
|
von Mehren M, Randall RL, Benjamin RS,
Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane
JM, et al: Soft tissue sarcoma, version 2.2018, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:536–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ducimetière F, Lurkin A, Ranchère-Vince D,
Decouvelaere AV, Péoc'h M, Istier L, Chalabreysse P, Muller C,
Alberti L, Bringuier PP, et al: Incidence of sarcoma histotypes and
molecular subtypes in a prospective epidemiological study with
central pathology review and molecular testing. PLoS One.
6:e202942011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bachmann R, Eckert F, Gelfert D, Strohäker
J, Beltzer C and Ladurner R: Perioperative strategy and outcome in
giant retroperitoneal dedifferentiated liposarcoma-results of a
retrospective cohort study. World J Surg Oncol. 18:2962020.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hassan I, Park SZ, Donohue JH, Nagorney
DM, Kay PA, Nasciemento AG, Schleck CD and Ilstrup DM: Operative
management of primary retroperitoneal sarcomas: A reappraisal of an
institutional experience. Ann Surg. 239:244–250. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hirata M, Asano N, Katayama K, Yoshida A,
Tsuda Y, Sekimizu M, Mitani S, Kobayashi E, Komiyama M, Fujimoto H,
et al: Integrated exome and RNA sequencing of dedifferentiated
liposarcoma. Nat Commun. 10:56832019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nishio J, Nakayama S, Nabeshima K and
Yamamoto T: Biology and management of dedifferentiated liposarcoma:
State of the art and perspectives. J Clin Med. 10:32302021.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Messiou C, Moskovic E, Vanel D, Morosi C,
Benchimol R, Strauss D, Miah A, Douis H, van Houdt W and Bonvalot
S: Primary retroperitoneal soft tissue sarcoma: Imaging
appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol.
43:1191–1198. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Capece M, Creta M, Calogero A, La Rocca R,
Napolitano L, Barone B, Sica A, Fusco F, Santangelo M, Dodaro C, et
al: Does physical activity regulate prostate carcinogenesis and
prostate cancer outcomes? A narrative review. Int J Environ Res
Public Health. 17:14412020. View Article : Google Scholar : PubMed/NCBI
|
11
|
Strocchi E, Iaffaioli RV, Facchini G,
Mantovani G, Ricci S, Cavallo G, Tortoriello A, D'Angelo R, Formato
R, Rosato G, et al: Stop-flow technique for loco-regional delivery
of high dose chemotherapy in the treatment of advanced pelvic
cancers. Eur J Surg Oncol. 30:663–670. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Santangelo M, Esposito A, Tammaro V,
Calogero A, Criscitiello C, Roberti G, Candida M, Rupealta N,
Pisani A and Carlomagno N: What indication, morbidity and mortality
for central pancreatectomy in oncological surgery? A systematic
review. Int J Surg. 28 (Suppl 1):S172–S176. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kilpatrick SE: Dedifferentiated
liposarcoma: A comprehensive historical review with proposed
evidence-based guidelines regarding a diagnosis in need of further
clarification. Adv Anatomic Pathol. 28:426–438. 2021.PubMed/NCBI
|
14
|
Baldini EH, Wang D, Haas RL, Catton CN,
Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C,
Guadagnolo BA, et al: Treatment guidelines for preoperative
radiation therapy for retroperitoneal sarcoma: Preliminary
consensus of an international expert panel. Int J Radiat Oncol Biol
Phys. 92:602–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Casali P, Abecassis N, Aro HT, Bauer S,
Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG,
Brodowicz T, et al: Soft tissue and visceral sarcomas: ESMO-EURACAN
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 29 (Suppl 4):iv51–iv67. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Callegaro D, Raut CP, Keung EZ, Kim T, Le
Pechoux C, Martin-Broto J, Gronchi A, Swallow C and Gladdy R:
Strategies for care of patients with gastrointestinal stromal tumor
or soft tissue sarcoma during COVID-19 pandemic: A guide for
surgical oncologists. J Surg Oncol. 123:12–23. 2021. View Article : Google Scholar : PubMed/NCBI
|
17
|
Keung EZ, Lazar AJ, Torres KE, Wang WL,
Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird
J, et al: Phase II study of neoadjuvant checkpoint blockade in
patients with surgically resectable undifferentiated pleomorphic
sarcoma and dedifferentiated liposarcoma. BMC Cancer. 18:9132018.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Roland CL, Keung EZ-Y, Lazar AJ, Torres
KE, Wang WL, Guadagnolo A, Bishop AJ, Lin HY, Hunt Y, Feig BW, et
al: Preliminary results of a phase II study of neoadjuvant
checkpoint blockade for surgically resectable undifferentiated
pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).
Am Soc Clin Oncol. 38:115052020. View Article : Google Scholar
|
19
|
Ferrara G, De Vincentiis L,
Ambrosini-Spaltro A, Barbareschi M, Bertolini V, Contato E,
Crivelli F, Feyles E, Mariani MP, Morelli L, et al: Cancer
diagnostic delay in northern and central Italy during the 2020
lockdown due to the coronavirus disease 2019 pandemic. Am J Clin
Pathol. 155:64–68. 2021. View Article : Google Scholar : PubMed/NCBI
|
20
|
Battisti F, Falini P, Gorini G, Sassoli de
Bianchi P, Armaroli P, Giubilato P, Giorgi Rossi P, Zorzi M,
Battagello J, Senore C, et al: Cancer screening programmes in Italy
during the COVID-19 pandemic: An update of a nationwide survey on
activity volumes and delayed diagnoses. Ann Ist Super Sanita.
58:16–24. 2022.PubMed/NCBI
|
21
|
Bracale U, Podda M, Castiglioni S,
Peltrini R, Sartori A, Arezzo A, Corcione F and Agresta F; CLOUD-19
Collaborative Group, : Changes in surgicaL behaviOrs dUring the
CoviD-19 pandemic. The SICE CLOUD19 Study. Updates Surg.
73:731–744. 2021. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mentrasti G, Cantini L, Vici P, D'Ostilio
N, La Verde N, Chiari R, Paolucci V, Crocetti S, De Filippis C,
Pecci F, et al: Rising incidence of late stage breast cancer after
COVID-19 outbreak. Real-world data from the Italian COVID-DELAY
study. Breast. 65:164–171. 2022. View Article : Google Scholar : PubMed/NCBI
|
23
|
Piscitelli P, Santoriello A, Buonaguro FM,
Di Maio M, Iolascon G, Gimigliano F, Marinelli A, Distante A,
Serravezza G, Sordi E, et al: Incidence of breast cancer in Italy:
Mastectomies and quadrantectomies performed between 2000 and 2005.
J Exp Clin Cancer Res. 28:862009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Pepe P, Pepe L, Pennisi M and Fraggetta F:
Prostate cancer diagnosis and management during one year of the
COVID-19 pandemic. Anticancer Res. 41:3127–3130. 2021. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ricciardiello L, Ferrari C, Cameletti M,
Gaianill F, Buttitta F, Bazzoli F, Luigi de'Angelis G, Malesci A
and Laghi L: Impact of SARS-CoV-2 pandemic on colorectal cancer
screening delay: Effect on stage shift and increased mortality.
Clin Gastroenterol Hepatol. 19:1410–1417.e9. 2021. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lazzerini M, Barbi E, Apicella A,
Marchetti F, Cardinale F and Trobia G: Delayed access or provision
of care in Italy resulting from fear of COVID-19. Lancet Child
Adolesc Health. 4:e10–e11. 2020. View Article : Google Scholar : PubMed/NCBI
|
27
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
28
|
Woll PJ, Reichardt P, Le Cesne A, Bonvalot
S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J,
Hogendoorn PC, et al: Adjuvant chemotherapy with doxorubicin,
ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC
62931): A multicentre randomised controlled trial. Lancet Oncol.
13:1045–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Gronchi A, Miah AB, Dei Tos AP, Abecassis
N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, et
al: Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS
Clinical Practice Guidelines for diagnosis, treatment and
follow-up(★). Ann Oncol. 32:1348–1365. 2021. View Article : Google Scholar : PubMed/NCBI
|
30
|
MacNeill AJ, Miceli R, Strauss DC,
Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro
D, Hayes AJ, Honoré C, et al: Post-relapse outcomes after primary
extended resection of retroperitoneal sarcoma: A report from the
Trans-Atlantic RPS Working Group. Cancer. 123:1971–1978. 2017.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Tan MC, Brennan MF, Kuk D, Agaram NP,
Antonescu CR, Qin LX, Moraco N, Crago AM and Singer S:
Histology-based classification predicts pattern of recurrence and
improves risk stratification in primary retroperitoneal sarcoma.
Ann Surg. 263:593–600. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhao X, Li P, Huang X, Chen L, Liu N and
She Y: Prognostic factors predicting the postoperative survival
period following treatment for primary retroperitoneal liposarcoma.
Chin Med J. 128:85–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Miura JT, Charlson J, Gamblin TC, Eastwood
D, Banerjee A, Johnston FM and Turaga KK: Impact of chemotherapy on
survival in surgically resected retroperitoneal sarcoma. Eur J Surg
Oncol. 41:1386–1392. 2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Villano AM, Zeymo A, Nigam A, Chan KS,
Shara N, Unger KR and Al-Refaie WB: Radical excision for
retroperitoneal soft tissue sarcoma: A national propensity-matched
outcomes analysis. Surgery. 168:831–837. 2020. View Article : Google Scholar : PubMed/NCBI
|
35
|
Guo Q, Zhao J, Du X and Huang B: Survival
outcomes of surgery for retroperitoneal sarcomas: A systematic
review and meta-analysis. PLoS One. 17:e02720442022. View Article : Google Scholar : PubMed/NCBI
|
36
|
Bonvalot S, Miceli R, Berselli M, Causeret
S, Colombo C, Mariani L, Bouzaiene H, Le Péchoux C, Casali PG, Le
Cesne A, et al: Aggressive surgery in retroperitoneal soft tissue
sarcoma carried out at high-volume centers is safe and is
associated with improved local control. Ann Surg Oncol.
17:1507–1514. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Bonvalot S, Rivoire M, Castaing M,
Stoeckle E, Le Cesne A, Blay JY and Laplanche A: Primary
retroperitoneal sarcomas: A multivariate analysis of surgical
factors associated with local control. J Clin Oncol. 27:31–37.
2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Singer S, Antonescu CR, Riedel E and
Brennan MF: Histologic subtype and margin of resection predict
pattern of recurrence and survival for retroperitoneal liposarcoma.
Ann Surg. 238:358–371. 2003. View Article : Google Scholar : PubMed/NCBI
|
39
|
van Houdt WJ, Fiore M, Barretta F,
Rutkowski P, Blay JY, Lahat G, Strauss D, Gonzalez RJ, Ahuja N,
Grignani G, et al: Patterns of recurrence and survival probability
after second recurrence of retroperitoneal sarcoma: A study from
TARPSWG. Cancer. 126:4917–4925. 2020. View Article : Google Scholar : PubMed/NCBI
|
40
|
Osuna-Soto J, Caro Cuenca T, Sanz-Zorrilla
A, Torrecilla-Martínez A, Ortega Salas R and Leiva-Cepas F:
Prognosis and survival of patients diagnosed with
well-differentiated and dedifferentiated retroperitoneal
liposarcoma. Cir Esp (Engl Ed). 100:622–628. 2022. View Article : Google Scholar : PubMed/NCBI
|
41
|
Dehner CA, Hagemann IS and Chrisinger JSA:
Retroperitoneal dedifferentiated liposarcoma. Am J Clin Pathol.
156:920–925. 2021. View Article : Google Scholar : PubMed/NCBI
|
42
|
Fodor M, Maglione M, Kogler P,
Kafka-Ritsch R, Ofner D and Perathoner A: Challenges in the
treatment of a giant retroperitoneal liposarcoma. Ann Ital Chir.
9:S2239253X20033162. 2020.PubMed/NCBI
|
43
|
Inoue K, Higaki Y and Yoshida H: Giant
retroperitoneal liposarcoma. Int J Urol. 12:220–222. 2005.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Kanthala L, Ray S, Aurobindo Prasad Das S,
Nundy S and Mehta N: Recurrent giant retroperitoneal liposarcoma:
Review of literature and a rare case report. Ann Med Surg.
65:1023292021. View Article : Google Scholar : PubMed/NCBI
|
45
|
Galatola R, Stanzione A, Sirignano C,
Mainolfi C, Guadagno E, Carlomagno N, Insabato L, Santangelo M and
Maurea S: Giant Epithelioid Angiomyolipoma: An imaging-related
differential diagnosis among Fat-containing renal masses. Clin
Genitourin Cancer. 18:e5–e9. 2020. View Article : Google Scholar : PubMed/NCBI
|
46
|
Czeyda-Pommersheim F, Menias C, Boustani A
and Revzin M: Diagnostic approach to primary retroperitoneal
pathologies: What the radiologist needs to know. Abdom Radiol (NY).
46:1062–1081. 2021. View Article : Google Scholar : PubMed/NCBI
|
47
|
Trans-Atlantic RPS Working Group, :
Management of recurrent retroperitoneal sarcoma (RPS) in the adult:
A consensus approach from the Trans-Atlantic RPS Working Group. Ann
Surg Oncol. 23:3531–3540. 2016. View Article : Google Scholar : PubMed/NCBI
|
48
|
Dubois-Silva A and Barbagelata-Lopez C:
Retroperitoneal dedifferentiated liposarcoma. Intern Emerg Med.
14:619–620. 2019. View Article : Google Scholar : PubMed/NCBI
|
49
|
Nijhuis PH, Sars PR, Plaat BE, Molenaar
WM, Sluiter WJ and Hoekstra HJ: Clinico-pathological data and
prognostic factors in completely resected AJCC stage I–III
liposarcomas. Ann Surg Oncol. 7:535–543. 2000. View Article : Google Scholar : PubMed/NCBI
|
50
|
Karadayi K, Yildiz C, Karakus S, Kurt A,
Bozkurt B, Soylu S, Cicekli AA, Egilmez R and Cetin A:
Well-differentiated abdominal liposarcoma: Experience of a tertiary
care center. World J Surg Oncol. 13:1662015. View Article : Google Scholar : PubMed/NCBI
|
51
|
Tseng WW, Madewell JE, Wei W, Somaiah N,
Lazar AJ, Ghadimi MP, Hoffman A, Pisters PW, Lev DC and Pollock RE:
Locoregional disease patterns in well-differentiated and
dedifferentiated retroperitoneal liposarcoma: Implications for the
extent of resection? Ann Surg Oncol. 21:2136–2143. 2014. View Article : Google Scholar : PubMed/NCBI
|
52
|
Stilidi IS, Nikulin MP, Nered SN, Davydov
MM, Bolotskiĭ VI and Gubina GI: Combined operations by
retroperitoneal liposarcomas. Khirurgiia (Mosk). 20–25. 2013.(In
Russian). PubMed/NCBI
|
53
|
Argadjendra M, Napitupulu R, Yudadi R,
Hoetama S and Wibowo HS: Kidney sparing giant retroperitoneal
liposarcoma: Case report and literature review. Int J Surg Case
Rep. 56:70–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
54
|
Agrusa A, Di Buono G, Buscemi S, Randisi
B, Gulotta L, Sorce V, Badalamenti G, Albano D, Galia M, Romano G
and Gulotta G: Dedifferentiated retroperitoneal large liposarcoma
and laparoscopic treatment: Is it possible and safe? The first
literature case report. Int J Surg Case Rep. 57:113–117. 2019.
View Article : Google Scholar : PubMed/NCBI
|
55
|
Xiao J, Liu J, Chen M, Liu W and He X:
Diagnosis and prognosis of retroperitoneal liposarcoma: A single
Asian center cohort of 57 Cases. J Oncol. 2021:75940272021.
View Article : Google Scholar : PubMed/NCBI
|
56
|
Ferrarese A, Pozzi G, Borghi F, Marano A,
Delbon P, Amato B, Santangelo M, Buccelli C, Niola M, Martino V and
Capasso E: Malfunctions of robotic system in surgery: Role and
responsibility of surgeon in legal point of view. Open Med (Wars).
11:286–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
57
|
Liu H, Hu T, Li Y, Yue Z, Zhang F and Fu
J: Successful intraoperative management in patients with abdominal
compartment syndrome induced by giant liposarcomas: Two case
reports. Medicine. 99:e225752020. View Article : Google Scholar : PubMed/NCBI
|
58
|
Santangelo M, De Rosa P, Spiezia S,
Spinosa G, Grassia S, Zuccaro M and Renda A: Healing of surgical
incision in kidney transplantation: A single transplant center's
experience. Transplant Proc. 38:1044–1046. 2006. View Article : Google Scholar : PubMed/NCBI
|
59
|
Effect of COVID-19 pandemic lockdowns on
planned cancer surgery for 15 tumour types in 61 countries: An
international, prospective, cohort study. Lancet Oncol.
22:1507–1517. 2021. View Article : Google Scholar : PubMed/NCBI
|
60
|
Hunger R, König V, Stillger R and Mantke
R: Impact of the COVID-19 pandemic on delays in surgical procedures
in Germany: A multi-center analysis of an administrative registry
of 176,783 patients. Patient Saf Surg. 16:222022. View Article : Google Scholar : PubMed/NCBI
|
61
|
Nel D: Strategies for recovery of a
surgical service in the COVID-19 era. S Afr J Surg. 60:154–159.
2022. View Article : Google Scholar : PubMed/NCBI
|
62
|
Mullangi S, Aviki EM, Chen Y, Robson M and
Hershman DL: Factors associated with cancer treatment delay among
patients diagnosed with COVID-19. JAMA Netw Open. 5:e22242962022.
View Article : Google Scholar : PubMed/NCBI
|